Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study (VOG-HD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02563418
Recruitment Status : Unknown
Verified September 2015 by University Hospital, Angers. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Corrected visual acuity >1/10
Aged over 18 years
Patient with the mutation that is to say the presence of an abnormal number of trinuclide: CAG> 38 in the first exon of the huntingtin gene.
Total Functional Capacity Scale (CFT) ≥ 3
Patients or trustworthy person who have not given their written consent, informed and signed.
Patients are not affiliated or who are not entitled to Social Security
Private patients of liberty by administrative or judicial decision, or patients supervision
Associated disease with neurological repercussions
Basal Ganglia Diseases
Central Nervous System Diseases
Nervous System Diseases
Heredodegenerative Disorders, Nervous System